Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Clinical trial NCT02605122 · TERMINATED
Trial details
- NCT number
- NCT02605122
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-03-21
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.